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In this work, a n e w  family of Conus peptides, the oA- 
conotoxins, which target the nicotinic acetylcholine re­
ceptor, is defined. The first members of this family have 
been characterized from the eastern Pacific species, Co­
nus purpurascens (the purple cone); three peptides that 
cause paralysis in fish were purified and characterized 
from milked venom. The sequence and disulfide bonding 
pattern of one of these, oA-conotoxin PIVA, is as follows:
GCCGSYONAACHOCSCKDROSYCGQ- nh2
where O  represents #rans-4-hydroxyproline. The two 
other peptides purified from C. purpurascens v e n o m  are 
the under-hydroxylated derivatives, [Pro13]oA-cono- 
toxin P I V A  and [Pro7,13] oA-conotoxin PIVA.
The peptides have been chemically synthesized in a 
biologically active form. Both electrophysiological ex­
periments and competition binding with o-bungarotox- 
in demonstrate that oA-PIVA acts as an antagonist of the 
nicotinic acetylcholine receptor at the postsynaptic 
membrane.
Many venomous anim als paralyze their prey by inhibiting  
communication between motor neurons and the skeletal m us­
cles they innervate. In many instances, a key molecular target 
of the neurotoxins in the venom is the nicotinic acetylcholine 
receptor (nAChR ) 1  in  the postsynaptic membrane at the neu­
romuscular junction. The first nAChR-targeted venom compo­
nents to be extensively characterized were the a-neurotoxins 
from snakes, typified by a-bungarotoxin from the Formosan 
krait, Bungarus m ulticinctus. Another large class of toxin mol­
ecules that inhibit the nAChR at the vertebrate neuromuscular 
junction are the a-conotoxins, which have been characterized  
from three different fish-hunting Indo-Pacific Conus species: 
Conus geographus  (1), Conus m agus (2), and Conus stria tu s  
(3, 4).
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All of the a-conotoxins from fish-hunting Indo-Pacific cone 
snails show high structural homology and a conserved se­
quence motif. The seven peptides that have been purified share 
the consensus sequence XCC(H/N)PACGXX(Y/F)XC. All of 
these peptides appear to be potent blockers of neuromuscular 
transm ission in teleosts but differ significantly in their potency 
when tested in other vertebrates; thus, a -conotoxin GI appears 
to be very potent in blocking the nicotinic acetylcholine recep­
tor at the neuromuscular junction of all vertebrates tested, 
while a -conotoxins SI and SII are highly potent in teleosts, but 
not m am mals (3, 4). In addition to the a-conotoxins from Indo- 
Pacific fish-hunting Conus, two a-conotoxins have been puri­
fied from non-fish-hunting Indo-Pacific species (5, 6 ). Although  
the peptides purified differ significantly from the consensus 
sequence given above, they do retain the sam e pattern of Cys 
residues (the “Cys framework”), i.e. X nCCXnCXnCXn.
Because this basic m otif was found in both fish-hunting and 
non-fish-hunting Conus species, it seemed reasonable to expect 
that all nAChR-targeted peptides in Conus venoms would 
share the sam e conserved a -conotoxin Cys framework. In this 
report, we describe a novel nAChR-targeted conotoxin from C . 
purpurascens, the purple cone (Fig. 1). C. purpurascens is def­
initely a piscivorous snail, and it was therefore a surprise to 
find that in this species, the group of peptides that blocks 
nicotinic acetylcholine receptors does not have a Cys frame­
work typical of a -conotoxins.
A unique feature of the study described below is that in 
contrast to all previous biochemical studies on Conus venoms, 
which were carried out w ith dissected venom ducts, the venom  
used here was milked from living anim als. The m ilking proce­
dure we have developed allows us to harvest much larger 
amounts of venom from relatively few cone snail specimens.
m a t e r i a l s  a n d  m e t h o d s
Venom Collection and Preparation—C. purpurascens specimens (3-5 
cm in length) were collected from the  Gulf of California. Because a 
sufficient num ber of C. purpurascens specimens to prepare venom from 
dissected ducts for biochemical purification was not available, C. pur- 
purascens were milked approximately twice a week. A goldfish was 
placed in front of the  snail to be milked and in most instances, this 
elicited full extension of the  proboscis (see Fig. 1B). A surrogate fish 
consisting of a microcentrifuge tube covered with a latex membrane, cut 
out from a condom or a glove and overlaid with a fresh goldfish fin, was 
then  substituted for the  goldfish a t the  tip of the  proboscis (see Fig. 2). 
The snail would harpoon the  surrogate and typically eject about 5 ^ l of 
venom; the  harpoon was cut with scissors after ejection of the  venom. 
The goldfish was fed to the  snail, and the  snail was retu rned  to its 
aquarium . The venom was centrifuged to the  bottom of the  tube and 
pooled together w ith previous milkings from the  same snail. For the 
general purification described below, crude milked venom from many 
snails was combined.
There seemed to be considerable variation in how often it was pos­
sible to milk individual snails. Some specimens seemed unable or u n ­
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Fig. 1. A, a specimen of the  purple cone, 
C. purpurascens, from the  Cocos Islands, 
in the  E astern  Pacific m arine province. B, 
C. purpurascens with its proboscis ex­
tended, in response to the  presence of a 
fish. A dose of venom (about 5 ^l) has 
been transferred  from the venom duct to 
the  proboscis. If the  snail is able to strike 
the  fish, it will inject the  venom through a 
disposable harpoon-like tooth, which it 
has already transferred  from a quiver­
like organ, the  radula sac, to the  tip  of the  









Fig. 2. M ilking p rocedu re . A, a fish is 
placed in front of the  snail un til it extends 
its proboscis. The collection tube (surro­
gate fish) is quickly substitu ted  for the 
fish as the  snail is about to strike. B, once 
the  snail has harpooned the  collection 
tube, the  harpoon is cut off. Right panel 
shows the  collection tube assembly. The 
cap of a microcentrifuge tube is hollowed 
out and placed over a m em brane with a 
cut up fish ta il to seal the  top of the  tube. 
C. purpurascens will generally be reluc­
tan t to strike unless the  tip of its probos­
cis actually contacts fish tissue; the  fish 
tail suffices for th is purpose. Once the 
venom has been collected, the  microcen­
trifuge tube is resealed w ith its own cap 
and some parafilm, and the  venom is col­
lected by centrifugation.
majority of the  specimens of C. purpurascens could be milked regularly 
twice a week. Most of the  specimens of C. purpurascens could be milked 
on this schedule for 6 m onths to a year. Among the  other Conus species 
milked by th is procedure are: C. striatus, Conus obscurus, Conus ster- 
cusmuscarum , Conus ermineus, Conus monachus and Conus catus.
Peptide Purification by HPLC—A preparative scale reversed-phase 
HPLC was used for the  first line purification of the  milked venom. 
One-half ml of milked venom was diluted with 10 ml of 0.1% trifluoro- 
acetic acid solution and spun for a few m inutes in a bench top mi- 
crofuge. The supernatant was applied to a C18 Vydac preparative col­
um n (22 X 250 mm; 20 ml/min) w ith a guard column (22 X 50.8 mm). 
As a secondary purification, a C18 Vydac analytical column (218TP54, 
4.6 X 250 mm;1 ml/min) was used. HPLC buffers were 0.1% trifluoro­
acetic acid in  w ater (buffer A) and 0.085% trifluoroacetic acid in 90% 
CH3CN (buffer B) for preparative runs and 0.092% trifluoroacetic acid 
in 60% acetonitrile for analytical runs. For both preparative and ana­
lytical runs, the  peptides were eluted w ith a linear gradient of 1% buffer 
B increase/min. The C18 analytical column was also used for purifying 
alkylated peptides for amino acid sequence analysis.
Analysis of Covalent Structure—Three closely related peptides were 
isolated, which differ solely in hydroxylation of th e ir proline residues; 
fully hydroxylated peptide is designated aA-conotoxin PIVA, with the 
others being assigned derivative status.
Primary Structure—Disulfides were reduced by TCEP, and the  lin­
ear peptide was purified and alkylated with 4-vinylpyridine as de­
scribed by Gray (7). The pyridylethylated peptide was repurified by
HPLC, and a sample was analyzed in an ABI model 477A sequencer. A 
second sample was digested w ith endoproteinase Lys-C (18 h, 37 °C); 
the  fragm ents were isolated by HPLC and subjected to sequencing 
and/or m ass analysis.
Disulfide Connectivity—N atural aA-conotoxin PIVA was analyzed by 
the  partial reduction method of Gray (7, 8), suitable reduction condi­
tions being established by small scale trials. To obtain partially reduced 
interm ediates, 10 nmol of peptide in HPLC effluent and 20 mM TCEP in 
0.17 M sodium citrate  (pH 3) were preequilibrated to 61 °C for 5 min. 
Equal volumes of the  reactants were mixed and incubated a fu rther 2 
m in before injection onto the  HPLC column. E luted peptides were 
immediately frozen (pH 2.0) a t —20 °C to minimize disulfide exchange. 
They were individually thawed, repurified, and immediately alkylated 
w ith 2.2 M iodoacetamide using the  rapid procedure of Gray (7). The 
carboxyamidomethylated peptides were desalted, and th e ir residual 
disulfides were reduced and alkylated with 4-vinylpyridine. Sequencer 
analysis was then  used to determine the  positions of Cys(cam) and 
Cys(pe) residues, thus establishing which residues had been free or 
bridged. Analysis of two interm ediates was sufficient to deduce the 
disulfide connectivity.
Mass Spectrometry—Positive ion LSIMS spectra were obtained using 
a Jeol JM S HX110 double-focusing spectrometer, fitted w ith a Cs+ ion 
gun operated at +30 kV.
Solid Phase Peptide Synthesis—aA-Conotoxin PIVA was built using 
standard  Fmoc chemistry on an ABI model 430A peptide synthesizer, 





























Fig. 3. Panel A, reversed-phase HPLC chromatogram of C. purpura- 
scens milked venom. 0.5 ml of milked venom was injected into a C18 
Vydac preparative column, and peptides were eluted with a gradient of 
CH3CN (0-36% ) in trifluoroacetic acid as described under “M aterials 
and Methods.” Peaks A, B, and C with arrows correspond to th ree  forms 
of aA-conotoxin PIVA. Panel B, fu rther purification of peak A  with an 
analytical C18 Vydac column. A small portion of peak A  was purified 
using a gradient of CH3CN (6~24%) in trifluoroacetic acid as described 
under “M aterials and Methods.” Panel C, the  peptide purified from 
panel B was reloaded on the  column and eluted under the  same condi­
tions as panel B. A single homogeneous peak was obtained.
derivative, dicyclohexylcarbodiimide, and hydroxybenzotriazole. All 
amino acids were from Bachem (Torrance, CA) with side-chain protec­
tion: pentamethylchromansulfonyl (Arg); trity l (Asn, Cys, Gln, His); 
t-butyl (Asp, Hyp, Ser, Tyr); t-butyloxycarbonyl (Lys). At the  completion 
of synthesis, the  term inal Fmoc group was removed by a standard  
machine cycle.
Peptide was removed from the  resin and deprotected by trea tm en t (2 
h, 20 °C) w ith trifluoroacetic acid/H2O/ethanedithiol/phenol/thioanisole 
(36/2/1/3/2 by volume), and the  whole m ixture was filtered rapidly into 
t-butyl m ethyl e ther at —10 °C. The precipitate was collected by cen­
trifugation, dissolved in 60% CH3CN containing 0.092% trifluoroacetic 
acid, and diluted 10-fold w ith 0.1% trifluoroacetic acid in water. L inear 
peptide was purified by reversed-phase HPLC on a C18 preparative 
column (Vydac 218TP1022, 20 ml/min), w ith a gradient of CH3CN 
(6-30%) in 0.1% trifluoroacetic acid. The peptide solution was diluted to 
approximately 20 ^M, glutathione was added to give final concentra­
tions of 1.0 mM reduced and 0.5 mM oxidized, and the  pH was adjusted 
to 7.5 with NaOH.
[Pro7,13] Conotoxin PIVA was built using standard  t-butyloxycar- 
bonyl chemistry on a Beckman 990B synthesizer; couplings were car­
ried out with dicyclohexylcarbodiimide in dimethylformamide or dichlo- 
romethane/dimethylformamide. All amino acids were from Bachem 
(Torrance, CA). Side-chain protection, synthetic methodology, cleavage, 
a ir oxidation and desalting on Bio-Rex 70 were essentially as described 
for w-conotoxin GVIA (9). H istidine was protected as the  p-toluenesul- 
fonyl derivative and coupled using hydroxybenzotriazole and benzotria- 
zol-1-yl-oxy-tris-(dimethylamino)phosphinium hexafluorophosphate.
Purification was carried out on a Vydac C18 column (5 X 30 cm) using 
a gradient of CH3CN in TEAP buffer at pH 5.30 (6-21%/60 min; 100 
ml/min). Fractions were collected and screened for purity by analytical 
HPLC on a Vydac C18 column (0.46 X 25 cm) eluted isocratically with 
16.2% CH3CN in 0.1% trifluoroacetic acid (2 ml/min). Samples were also 
analyzed by capillary electrophoresis a t 20 kV, using 0.1 M sodium 
phosphate a t pH 2.50 and a fused silica capillary (50 cm X 75 ^m). 
Fractions of the  highest purity were pooled and repurified/desalted on 
the  same preparative column, using a gradient of CH3CN in 0.1%
trifluoroacetic acid (6-36%/60 min; 100 ml/min).
Electrophysiology—Wire electrodes were used to record extracellular 
synaptic currents from populations of endplates in frog cutaneus pec­
toris preparations th a t had been trea ted  with a-bungarotoxin to irre ­
versibly a ttenuate  the  synaptic response to a subthreshold level as 
described previously (10).
Biological Assays—Intraperitoneal injections into goldfish and 10­
14-day-old Swiss W ebster mice, and in tracranial injection into mice 
were performed as described previously (11).
Binding Assays—Binding assays were performed using a m embrane 
fraction enriched in nAChR prepared from Torpedo californica electro- 
plax (Pacific Bio-Marine, Venice, CA). All procedures were performed at 
0 -4  °C. Fifty ml of buffer (0.25 M NaCl, 0.02 M HEPES, 2 mM EDTA, pH 
7.4) containing 1 mM phenylmethylsulfonyl fluoride, 1 ^M pepstatin, 
and 2 ^M leupeptin were added to 50 g of frozen Torpedo tissue, followed 
by processing in a Sorvall Omnimixer (30 s on highest setting, 30 s off, 
for a to tal of 6 min) and 5 stroke cycles in a Dounce homogenizer. Large 
particulate m atter was removed by centrifugation at 3000 X g  for 10 
min. Membrane fragm ents were collected by centrifugation of the  su­
pernatan t at 17000 X g  for 50 min. The resulting pellet was resus­
pended in 10 ml of buffer and stored in small aliquots a t —70 °C. 
Torpedo receptors (0.38 pmol of a-bungarotoxin binding sites/mg of 
protein, 2 ^g  protein/0.1 ml assay) were diluted into 0.02 M HEPES, pH 
7.4, 5 mM EDTA, 0.5 mg/ml bovine serum  albumin, and 0.5 mg/ml 
lysozyme and preincubated for 30 min at room tem perature w ith either 
unlabeled a-bungarotoxin or with various concentrations of synthetic 
PIVA, followed by a 15-min incubation w ith a-[125I]bungarotoxin (Am- 
ersham  Corp., 2000 Ci/mmol, 12.5 pmol/assay). Unbound a-bungaro- 
toxin was separated from receptor by centrifugation in a m icrocentri­
fuge for 3 min at —15,000 X g. The pellet was washed with 0.1 ml of 0.02 
M HEPES, pH 7.4, and 5 mM EDTA, followed by centrifugation. Radio­
activity in pellet and supernatan t was determined using a Packard 
M ulti-Prias y counter. Nonspecific binding was typically less th an  
2.5% of to ta l binding, determ ined by preincubation w ith 0.01 mM 
unlabeled a-bungarotoxin.
RESULTS
Toxin Purification and  C haracterization—A chromato­
graphic profile of crude milked venom is shown in Fig. 3A. 
A rrow s indicate three fractions that caused paralysis upon 
injection into goldfish, and that proved to be proline-hydroxyl- 
ation isoforms of a single peptide. Further purification of pep­
tide A, in which all three proline residues were hydroxylated, is 
shown in Fig. 3, B  and C. Peptides B and C were similarly  
purified.
Am ino A cid  Sequences—Sequencer analysis of reduced and 
alkylated peptide A is reported in Table I. A single unambigu­
ous sequence was obtained for 25 cycles. Attempts to obtain 
LSIMS m ass spectra were initially unsuccessful because of 
lim ited amounts of material; all of these peptides have consist­
ently given a 2 0 -50-fold  lower sensitivity than is typical for 
peptides in this size range. Lys-C digestion of pyridylethylated  
toxin yielded two peptides. One of these corresponded in mass 
to that expected for the amidated C-terminal fragment (resi­
dues 18-25: monoisotopic M H+ observed, 1045.48; theoretical, 
1045.45). No successful analysis was achieved w ith the other. 
The deduced linear structure of the toxin is as follows: A = 
PIVA, GCCGSYONAACHOCSCKDROSYCGQ-NH2, where O 
represents trans-4-hydroxyproline. By a similar methodology, 
peptides B and C were shown to be the under-hydroxylated 
peptides: B = [Pro1 3 ]PIVA, GCCGSYONAACHPCSCKDROSY- 
CGQ-NH2; C = [Pro7 ,1 3 ]PIVA, GCCGSYPNAACHPCSCK- 
DROSYCGQ-NH2.
After completion of the synthesis of peptides A and C (below), 
and completion of the biological characterization, more snails 
became available, allowing reisolation of all three isoforms. 
LSIMS analysis was successfully carried out on intact peptides, 
and the monoisotopic molecular ions M H+ were in agreem ent 
w ith those predicted from the above sequences: A (observed, 
2648.0; theoretical, 2647.93); B (observed, 2631.9; theoretical,
2631.93); C (observed, 2615.9; theoretical, 2615.94).






























Sequence analysis o f aA-conotoxin PIVA 
This amino acid sequence above was obtained for peak A from Fig. 3A, 
using procedure 1 described under “M aterials and Methods.” The data 
for the  other peaks (B and C in Fig. 3A) are not shown.
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of native peptide isolated from venom. Reaction w ith 10 mM 
TCEP at pH 3.0 (2 min, 61 °C) gave a suitable distribution of 
partially reduced peptides (Fig. 4A). Three major interm ediates 
(interm ediates 1 -3) are evident, and others are indicated by 
broadening of the original peptide peak N. Interm ediates 1 and
3 were purified and alkylated w ith iodoacetamide to label free 
thiols; residual bridges were then reduced and alkylated with  
4-vinylpyridine. Sequencer analysis of interm ediate 1 released  
Cys(cam) at cycles 3 and 11, while Cys(pe) was released at 
cycles 2, 14, 16, and 23. A nalysis of interm ediate 3 released  
Cys(cam) at cycles 2, 3, 11, and 16 and Cys(pe) at cycles 14 and 
23. All other amino acids were identical to those shown in Table
I, fully confirming the original sequence assignm ent. Thus the 
bridging pattern is [Cys2 -Cys16; Cys3 -Cys11; Cys1 4 -Cys23], and 
the two interm ediates lie on the reduction pathway shown in  
Fig. 4B. This particular disulfide topology has not previously 
been found in conotoxins.
Peptide Synthesis—Peptides A and C were chosen as syn­
thetic targets to provide sufficient material for more detailed  
biological study. Peptide A was constructed using Fmoc chem­
istry, linear peptide was purified by HPLC, and disulfide 
bridges were allowed to form in the presence of a glutathione 
redox buffer. Under these conditions greater than 50% of the 
product eluted at the position corresponding to natural peptide. 
The misfolded material was recycled to obtain more of the 
correct form. After further HPLC purification in the trifluoro- 
acetic acid system  the peptide was judged to be 9 7 - 9 8 % pure by 
analytical HPLC in TEAP buffers. Co-elution experim ents con­
firmed identical chromatographic behavior of natural and syn­
thetic products. LSIMS analysis of synthetic peptide indicated  
the correct monoisotopic MH+ (observed, 2647.9; theoretical,
2647.93). As w ith the natural peptide, ionization w as very 
inefficient, and relatively large amounts of sample were 
required.
Peptide C was constructed using t -butyloxycarbonyl chem is­
try. Crude linear peptide w as air-oxidized by stirring at pH 7.0; 
the reaction was judged complete after 4 days. Purification was
Fig. 4. A, reversed-phase HPLC chromatogram of aA-conotoxin 
PIVA, partially reduced by TCEP (10 mM, pH 3, 5 min at 61 °C). The 
absorbance peaks labeled 1, 2 , and 3 correspond to the  partially reduced 
peptides PR1, PR2, and PR3; N  and R  correspond to the  native and 
completely reduced peptides, respectively. An analytical C18 Vydac 
column was used for separating individual peaks using a gradient of 
CH3CN (6-30%) in trifluoroacetic acid (see “M aterials and Methods”). 
B , disulfide bridge arrangem ents in native and partially  reduced 
peptides.
carried out by adsorption onto Bio-Rex 70 cation exchanger, 
followed by preparative HPLC using TEAP buffers, w ith a final 
desalting and purification by HPLC in the trifluoroacetic acid 
system . TEAP at pH 5.30 was found to be preferable to the 
usual TEAP, pH 2.25, since the latter did not yield high purity 
fractions or a good yield of purified peptide. The advantage of 
using TEAP at various pH values has been recognized previ­
ously in the purification of synthetic peptides (12). The result­
ing peptide, which co-eluted w ith material isolated from 
venom, appeared to be 99% pure as analyzed by analytical 
HPLC and capillary electrophoresis. LSIMS showed the ex­
pected molecular ion MH+ (observed, 2616.0; theoretical,
2615.94).
The major refolded material for both synthetic peaks A and 
C proved to be identical to their native counterparts; a mixture 
of native and synthetic peptide in each case gave a single sharp 
peak upon HPLC analysis (see Fig. 5). Both synthetic peptides 
were found to be biologically active by the fish paralysis assay. 
The chemical synthesis of these two peptides therefore con­
firms the sequence assignm ents given above, including the 
C-terminal amidation.
Because these peptides, like the a-conotoxins, inhibit the 
nicotinic acetylcholine receptor (see below), we have designated  
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Fig. 5. A, reversed-phase HPLC chromatogram of synthetic aA-cono- 
toxin PIVA (fully hydroxylated peptide). The peptide was eluted from a 
C18 Vydac analytical column w ith a gradient of CH3CN (6-24%) in 
trifluoroacetic acid (see “M aterials and Methods”). B, co-elution exper­
iment. Equal amounts of the  synthetic and native peptides were mixed 
and co-eluted using the  same column, gradient, flow rate, and buffers as 
in panel A.
cates the new structural class . 2  Since peaks B and C are clearly 
under-hydroxylated derivatives of peak A, we designate them  
as [Pro1 3 ]aA-conotoxin PIVA and [Pro7 ,1 3 ]aA-conotoxin PIVA. 
However, the proportion of the under-hydroxylated forms 
(peaks B and C) relative to the fully hydroxylated toxin (peak  
A) varies from one milked venom preparation to the next. 
Although we previously detected under-hydroxylated forms of 
other conotoxins (see, for example Ref. 13), they have never 
been major species in any venom previously characterized. The 
under-hydroxylated forms may arise as a consequence of arti­
ficial aquarium conditions.
aA-conotoxin PIVA Blocks the N icotinic Acetylcholine Recep­
tor—The basis for the paralytic activity of aA-conotoxin PIVA 
was investigated by electrophysiological tests and binding ex­
perim ents. The effect of the toxin on the frog neuromuscular 
junction is shown in Fig. 6 A. The peptide clearly blocks the 
excitatory postsynaptic response. There w as no difference be­
tween the tim e course of the partially blocked response and the 
control (Fig. 6 B). The peptide blocked spontaneous miniature 
end plate potentials as well as the response to iontophoretically 
applied carbamylcholine without affecting the resting potential 
(results not shown), indicating that the peptide acts postsyn- 
aptically. These electrophysiological results strongly suggest 
that the peptide directly inhibits nicotinic acetylcholine
2 The peptides in th is report define both a new Conus peptide family 
(aA), as well as a novel structural class. As we will detail elsewhere, we 
use the  Roman num eral IV for all Conus peptides w ith the  Cys fram e­
work -CCXnCX2CXCXnC-. We have characterized other conotoxin fam­
ilies of the  same structural class but with different pharmacological 
specificities; these have the  same disulfide framework but are not 
targeted  to nicotinic acetylcholine receptors. All members of a given 
Conus peptide family share both a conserved Cys framework as well as 
a common pharmacological mechanism. We reta in  the  Greek le tter a for 
all Conus peptide families th a t inhibit the  nAChR by binding to the 
ligand site a ; to distinguish the  new peptides from the  a-conotoxins, we 
designate the  former as aA-conotoxins. An additional distinction is th a t 
the  distance between the  first pa ir of cysteines and the  next cysteine 
residue in the  prim ary sequence is 7 amino acids in aA-conotoxin PIVA 
but 3 -4  amino acids in all a-conotoxins.
Fig. 6 . A, exposure to 10 ^M [Pro7,13]aA-conotoxin PIVA reversibly 
blocks endplate currents. The motor nerve of a frog cutaneus pectoris 
muscle whose ACh receptors were partially blocked by a-bungarotoxin 
was stim ulated every 30 s, and the  evoked synaptic currents from a 
population of endplates was recorded extracellularly (see “M aterials 
and Methods”). Peak amplitudes of the  evoked synaptic currents are 
plotted as a function of time. [Pro7,13]aA-conotoxin PIVA was applied at 
tim e 0. Open circles, responses before exposure to, and during washout 
of, toxin. Closed circles, responses in the  presence of toxin. The response 
was rapidly blocked when the  peptide was introduced and recovered 
relatively slowly upon peptide washout. B, exposure to 1 ^M [Pro7,13]aA- 
conotoxin PIVA reduces the  endplate current amplitude 3-fold without 
affecting its tim e course. Bold solid trace, control response in the  ab­
sence of toxin. Finer solid trace, response in the  presence of toxin. 
Dotted trace, response in the  presence of toxin normalized with respect 
to the  control response by 3-fold expansion of its vertical axis. The 
normalized trace of the  response in toxin coincides with the  control 
trace, indicating th a t the  toxin a ttenuates the  postsynaptic response 
without altering its kinetics. Each trace represents the  average of eight 
responses obtained under each condition. Rapid transien ts a t t  =  2 ms 
are stim ulus artifacts.
receptors.
This possibility was supported by competition binding exper­
im ents w ith  a-[1 2 5 I]bungarotoxin used as a reporter for recep­
tor occupancy of high affinity sites in the Torpedo electric 
organ, which are w ell-established to be on the nicotinic acetyl­
choline receptor. The results of binding experim ents w ith aA- 
conotoxin PIVA and the Pro7 , 1 3  derivative are shown in Fig. 7. 
Both peptides competitively inhibit a -bungarotoxin binding, 
indicating that these peptides target the macrosite that a -bun- 
garotoxin binds to on the Torpedo receptor.
A survey of the in vivo  biological activity of these peptides is 
shown in Table II.
DISCUSSION
The results described above establish that the major para­
lytic toxin in C. purpurascens venom targeted to nAChRs, 





























quence from all other nAChR-targeted peptides previously 
characterized from Conus venoms. D espite the striking struc­
tural divergence, the mechanism by which this peptide causes 
paralysis is nevertheless similar to the well-characterized 
a-conotoxins from other fish-hunting Conus species, i.e. the 
peptide blocks the ACh binding site of the nAChR at the neu­
romuscular junction.
Comparison of the sequence of this new toxin, aA-conotoxin 
PIVA, w ith previously characterized a -conotoxins is shown in 
Table III. W ith one exception (a-conotoxin SII), the latter tox­
ins have two disulfide bonds; in contrast, aA-PIVA has three. 
Furthermore, all paralytic a -conotoxins from fish-hunting Co- 
nus share the following conserved patterns of Cys and non-Cys 
amino acids, i.e. CCZ3 CZ5 C. The a-conotoxins from non-fish- 
hunting Conus species that have been described so far (5, 6 ), 
while having spacing different from that for fish-hunters as 
indicated above, nevertheless have the sam e Cys framework. 
In contrast, the new peptide, aA-PIVA, not only has a different
log [PIV] M
Fig. 7. C om petition  b ind ing  of PIVA versus a- [125I]bungaro- 
toxin. Competition binding with Torpedo electroplax m em brane was 
performed as described under “M aterials and Methods.” D ata points are 
the  m ean of th ree  determ inations a t each concentration. B0 is the 
amount of a-[125I]bungarotoxin bound in the  absence of competing 
peptide. The open circles and closed triangles are points for aA- and 
[Pro7,13]aA-conotoxin PIVA, respectively.
Table II 
Bioassay o f aA-conotoxin PIVA 
Peptide was injected intraperitoneally at a concentration of 0.5 nmol/ 
gram  of body mass. W eakness was defined for fish as loss of ability to 






aA-PIVA in fish 2.7 4.3
[Pro7'13]aA-PIVA in fish 3.2 5.0
aA-PIVA in mice 4.5 6.5
[Pro7,13]aA-PIVA in mice 4.3 7.2
Cys framework, but the spacing betw een the first pair of Cys 
residues and the third Cys is 7 amino acids instead of the 3 or 
4 amino acids found in the nine characterized a-conotoxins. 
Thus, the new peptide is the first member of a new family of 
nAChR-targeted Conus peptides. Homologs of the C. purpura- 
scens peptide will be designated aA-conotoxins (because of the 
divergence in the Cys framework, peptides belonging to this 
structural class will be given Roman numeral IV, as opposed to 
the regular a -conotoxins, which are always numbered I or II). 
In addition, Conus peptides w ith a Cys framework similar to 
that of PIVA but which are not targeted to the nAChR (and are 
therefore not aA-conotoxins) have also been characterized . 3
Thus, aA-PIVA is both the first member of a new family of 
Conus peptides, the aA-conotoxins, and the first representative 
of a new structural class of Conus peptides. The availability of 
a new group of nAChR-targeted Conus peptides that have 
significantly diverged from the a -conotoxin series provides new  
opportunities for probing the nAChR. Previously, reporter 
groups were attached to a -conotoxins at specific loci (14); such 
an approach can in principle be used to map the topology of the 
nAChR (15). Since Conus peptides are extensively cross-linked 
by disulfide bonds and are, therefore, fairly rigid, they provide 
a structurally discrete probe, which can be used to pinpoint the 
locations of residues in the receptor. Some a -conotoxins have 
been analyzed by m ultidim ensional NMR techniques (16, 17); 
sufficient amounts of aA-conotoxin PIVA have been synthe­
sized, and a structural analysis of these peptides by NMR 
methods is presently being carried out. o n ce  the structural 
work is complete, aA-PIVA could be a useful probe for the  
nAChR based on an entirely different structural framework 
from that of the a -conotoxins.
The degree of under-hydroxylation of proline residues in 
aA-conotoxin PIVA deserves comment. Different sam ples of 
m ilked C . purpurascens venom show considerable variation in 
the degree of under-hydroxylation; in some venom sam ples, the 
two under-hydroxylated species described above are present at 
higher levels than the completely hydroxylated aA-PIVA (in 
contrast to the venom sam ple shown in Fig. 3A ). Small differ­
ences in IC50s shown in Fig. 7 are seen reproducibly, raising  
the possibility that the different hydroxylated forms have func­
tional biological significance. We think that at least some of the 
under-hydroxylation observed may be an artifact of m aintain­
ing C. purpurascens  in  aquaria for extended periods of time. We 
have observed that several different Conus species become 
increasingly susceptible to pathology both in the periostracum  
and in laying down new shell if  kept in aquaria in artificial sea  
water. Thus, it is possible that some under-hydroxylated forms 
observed in the milked venom are present at lower levels in C . 
purpurascens  under natural conditions and that the under- 
hydroxylation observed may be a biochemical m anifestation of 
a progressive pathology that occurs in aquaria. It is possible 
that some factors necessary for proline hydroxylation may be-
3 G. Zafaralla, J . M. McIntosh, M. Grilley, L. J. Cruz, and B. M. 
o livera, unpublished results.
Table III
Conotoxin Sequence^ Source Reference
aA-PIVA GCCGSYONAACHOCSCKDROSYCGQ* C. purpurascens This work
a-GI ECCNPACGRHYSC* C. geographus 1
a-MI GRCCHPACGKNYSC* C. magus 2
a-SI ICCNPACGPKYSC* C. striatus 3
a-SII GCCCNPACGPNYGCGTSCS* C. striatus 4
From non-fish-hunting Conus 
a-Im l GCCSDPRCAWRC* C. imperialis 6
a-PnIA GCCSLPPCAANNPDYC* C. pennaceus 18
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come limiting. The pattern of under-hydroxylation suggests 
that the Pro residues are not equivalent as substrates for the 
hydroxylation enzym e, and that the ease of hydroxylation is in 
the order: Pro2 0  >  Pro7  >  Pro13. In any case, the results in Fig.
7  were unexpected and surprising, and further studies inves­
tigating functional effects of proline hydroxylation are clearly 
desirable.
C. purpurascens is believed to be the only fish-hunting Conus 
species in the eastern Pacific marine geographic province. It 
has probably been isolated from fish-hunting Indo-Pacific spe­
cies for an extended period of tim e. Its closest relative is 
thought to be C. erm ineus, the major fish-hunting Conus spe­
cies in the Atlantic marine province. An aA-conotoxin that 
differs significantly in sequence from aA-conotoxin PIVA has 
recently been identified in this species . 4  The discovery of the 
nAChR-targeted peptides in C. purpurascens that are so diver­
gent from those found in other Conus species raises the intrigu­
ing possibility that fish-hunting may have evolved more than  
once in the Conidae. It w ill be of interest to determine which  
Conus species use the aA-conotoxin family as nAChR ligands 
instead of members of the a -conotoxin family.
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